| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | At Haemokinesis, we deliver advanced blood diagnostic and testing technology that's safe, fast, accurate and reliable. We are solving the challenges of point-of-care (POC) / point-of-trauma (POT) blood diagnostics and the limitations of existing human blood group (immunohaematology) testing in hospitals and blood banks. We accelerate and simplify in-vitro diagnostic testing and analysis for medical professionals in order to improve patient outcomes and help save lives. Haemokinesis is committed to removing the barriers of access to the basic elements of healthcare around the world. Focused on blood group testing and emergency medicine. Haemokinesis provides safe and timely blood group testing as a fundamental requirement of a healthcare system and innovative point-of-care solutions in emergency medicine, the Company’s vision is to ensure anyone, anywhere has access to vital diagnostic technology. |
| Category: | Health & biotech |
| URL: | https://www.haemokinesis.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2011 |
| Address: | 16 Technology Circuit, Hallam, Victoria 3803, AU |
| State: | Victoria |
| Overseas Operations: | No |
| Twitter: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/haemokinesis/ |
| Founders: | |
| Awards won: | |
